Cargando…
SLC25A1-associated prognostic signature predicts poor survival in acute myeloid leukemia patients
Background: Acute myeloid leukemia (AML) is a heterogeneous malignant disease. SLC25A1, the gene encoding mitochondrial carrier subfamily of solute carrier proteins, was reported to be overexpressed in certain solid tumors. However, its expression and value as prognostic marker has not been assessed...
Autores principales: | Liu, Fangshu, Deng, Suqi, Li, Yue, Du, Juan, Zeng, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852877/ https://www.ncbi.nlm.nih.gov/pubmed/36685828 http://dx.doi.org/10.3389/fgene.2022.1081262 |
Ejemplares similares
-
Novel Gene Signature Reveals Prognostic Model in Acute Myeloid Leukemia
por: Qu, Ying, et al.
Publicado: (2020) -
CDK6 Is a Potential Prognostic Biomarker in Acute Myeloid Leukemia
por: Liu, Wei, et al.
Publicado: (2021) -
A Prognostic Autophagy-Related Long Non-coding RNA (ARlncRNA) Signature in Acute Myeloid Leukemia (AML)
por: Zhao, Chunxia, et al.
Publicado: (2021) -
The Prognostic Value and Function of HOXB5 in Acute Myeloid Leukemia
por: Chen, Miao, et al.
Publicado: (2021) -
Novel Prognostic Signature for Acute Myeloid Leukemia: Bioinformatics Analysis of Combined CNV-Driven and Ferroptosis-Related Genes
por: Han, Chunjiao, et al.
Publicado: (2022)